Quantcast
Last updated on April 17, 2014 at 11:49 EDT

Latest drug discovery Stories

2014-03-31 23:05:01

Dalton Medicinal Chemistry receives notice of renewal of award from NIDA of NIH to fund research of novel series of compounds to treat drug abuse and alleviate pain. Toronto, ON (PRWEB) March 31, 2014 Dalton Medicinal Chemistry has received notice that the award from the National Institute On Drug Abuse (NIDA) to research and discover a novel series of compounds with the potential to treat drug abuse and alleviate pain has been renewed. This work will be supported by NIDA of the National...

2014-03-31 04:20:51

CAMBRIDGE, England, March 31, 2014 /PRNewswire/ -- Convergence Pharmaceuticals Holdings Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has entered into a research alliance with Evotec, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology...

2014-03-27 16:25:12

Successful IPO Positions Company for Multiple Independent Catalysts Over Next 5 Quarters LA JOLLA, Calif., March 27, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced its financial results for the fourth quarter and year ended December 31, 2013. "2014 has the potential to be a transformative year for Auspex as...

2014-03-27 08:34:12

Cannabinoid Receptor 1 is most recent GPCR to be targeted by RuiYi's iCAPS platform LA JOLLA, Calif. and SHANGHAI, March 27, 2014 /PRNewswire/ -- RuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent corporate healthcare venture capital fund of GlaxoSmithKline, Merck Serono Ventures, the strategic corporate venture fund of Merck Serono, and Aravis SA. RuiYi has a pipeline of...

2014-03-26 23:24:54

Dr. Pierre-Allain Girod to Present on Data on Engineering CHO Cell Lines for Enhanced Production of Monoclonal Antibodies and Fc:Fusion Proteins Geneva, Switzerland (PRWEB) March 26, 2014 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the Company’s chief scientific officer, Pierre-Allain Girod, Ph.D., will present, “Selexis SURE CHO-Mplus™...

2014-03-26 08:28:59

- Study will evaluate whether MST-188 improves the effectiveness of rt-PA SAN DIEGO, March 26, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) announced today that it has initiated a phase 2, clinical proof-of-concept study of MST-188 in combination with recombinant tissue plasminogen activator (rt-PA) in patients with acute lower limb ischemia. Acute limb ischemia (ALI), an acute complication of peripheral arterial disease, describes a sudden decrease in perfusion...

2014-03-26 08:28:26

VANCOUVER, British Columbia, March 26, 2014 /PRNewswire/ -- Xenon Pharmaceuticals Inc. today announced the establishment of a new collaboration with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), for pain genetics, with the goal of discovering and validating new therapeutic targets and mechanisms for treating pain. The collaboration leverages Xenon's Extreme Genetics discovery platform to focus on rare phenotypes where individuals have an inability to perceive...

2014-03-25 23:21:59

New patient recruiting and retention eBook features marketing, social media, education, planning, communication, and other tips and strategies from leading clinical trials experts. San Francisco, CA (PRWEB) March 25, 2014 Mosio, an award-winning mobile software company providing solutions in clinical research, health services and other industries, announces the release of its new “Clinical Trials Patient Recruiting and Retention: Tips for Success” eBook. The company has partnered with...

2014-03-25 23:04:38

Pioneers and Visionaries in Genomics to Headline 13th Annual Conference Needham, MA (PRWEB) March 25, 2014 March 25, 2014 – Bio-IT World Expo, the premier event showcasing applications of IT and informatics to biomedical research and the drug discovery enterprise, today proudly announced its keynote speakers for its 13th annual conference and expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston. The annual Bio-IT World Conference & Expo, which unites more than...

2014-03-25 16:26:21

SD-560 is a Novel Oral Small Molecule for the Potential Treatment of Idiopathic Pulmonary Fibrosis and Other Fibrotic Conditions LA JOLLA, Calif., March 25, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the issuance of the following composition of matter and method of treatment patents covering its...